title: Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants.
abstract: Potential mechanisms underlying impaired chemotactic responsiveness of neonatal neutrophils were investigated. Two distinct chemoattractants were compared: bacterially derived N-formyl-methionyl-leucyl-phenylalanine (fMLP) and a unique chemotactic monoclonal antibody, designated DL1.2, which binds to a neutrophil antigen with an apparent molecular mass of 120 kDa. Chemotaxis of neutrophils toward fMLP, as well as DL1.2, was reduced in neonates when compared with adult cells. This did not appear to be a result of decreased fMLP receptor or DL1.2 antigen expression by neonatal neutrophils. fMLP, but not DL1.2, induced a rapid increase in intracellular calcium in adult and neonatal cells, which reached a maximum within 30 s. The calcium response of cells from neonates to fMLP was reduced when compared with adult cells, and an unresponsive subpopulation of neonatal neutrophils was identified. NF-kappaB nuclear binding activity induced by fMLP and DL1.2, as well as expression of the p65 NF-kappaB subunit and IkappaB-alpha, was also significantly reduced in neonatal cells, when compared with adult cells. In contrast, although fMLP, but not DL1.2, activated p42/44 and p38 mitogen-activated protein (MAP) kinases in neutrophils, no differences were observed between adults and neonates. Chemotaxis of adult and neonatal neutrophils toward fMLP and DL1.2 was also blocked to a similar extent by inhibitors of phosphatidylinositol 3-kinase, as well as an inhibitor of NF-kappaB. These findings indicate that reduced chemotactic responsiveness in neonatal neutrophils is a result of, at least in part, aberrations in chemoattractant-induced signaling. However, the biochemical pathways mediating this defect appear to be related to the specific chemoattractant.
authors.affiliation: Department of Pediatrics/Neonatology, UMDNJ-Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA. barryw@pol.net
authors.forename: B
authors.initials: B
authors.lastname: Weinberger
authors.forename: D L
authors.initials: DL
authors.lastname: Laskin
authors.forename: T M
authors.initials: TM
authors.lastname: Mariano
authors.forename: V R
authors.initials: VR
authors.lastname: Sunil
authors.forename: C J
authors.initials: CJ
authors.lastname: DeCoste
authors.forename: D E
authors.initials: DE
authors.lastname: Heck
authors.forename: C R
authors.initials: CR
authors.lastname: Gardner
authors.forename: J D
authors.initials: JD
authors.lastname: Laskin
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal; D002118:Calcium / Q000502:physiology; D002630:Chemotactic Factors; D002634:Chemotaxis, Leukocyte / Q000502:physiology*; D005312:Fetal Blood; D006801:Humans; D007231:Infant, Newborn; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009504:Neutrophils / Q000166:cytology / Q000502:physiology*; D015398:Signal Transduction
chemical_list: D000911:Antibodies, Monoclonal; D002630:Chemotactic Factors; D009240:N-Formylmethionine Leucyl-Phenylalanine; D002118:Calcium